Buchanan M - Search Results

1

Metastatic Breast Carcinoma-Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression.

Gui Y, Aguilar-Mahecha A, Krzemien U, Hosein A, Buchanan M, Lafleur J, Pollak M, Ferrario C, Basik M. Gui Y, et al. Among authors: buchanan m. Clin Cancer Res. 2019 Dec 1;25(23):7229-7242. doi: 10.1158/1078-0432.CCR-19-1268. Epub 2019 Sep 12. Clin Cancer Res. 2019. PMID: 31515454

2

A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.

Hosein AN, Livingstone J, Buchanan M, Reid JF, Hallett M, Basik M. Hosein AN, et al. Among authors: buchanan m. BMC Cancer. 2015 Mar 15;15:130. doi: 10.1186/s12885-015-1117-0. BMC Cancer. 2015. PMID: 25884794 Free PMC article.

3

Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.

Hamel S, Bouchard A, Ferrario C, Hassan S, Aguilar-Mahecha A, Buchanan M, Quenneville L, Miller W, Basik M. Hamel S, et al. Among authors: buchanan m. Breast Cancer Res Treat. 2010 Feb;120(1):47-57. doi: 10.1007/s10549-009-0364-7. Epub 2009 Mar 20. Breast Cancer Res Treat. 2010. PMID: 19301121

4

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.

Hassan S, Buchanan M, Jahan K, Aguilar-Mahecha A, Gaboury L, Muller WJ, Alsawafi Y, Mourskaia AA, Siegel PM, Salvucci O, Basik M. Hassan S, et al. Among authors: buchanan m. Int J Cancer. 2011 Jul 1;129(1):225-32. doi: 10.1002/ijc.25665. Epub 2010 Nov 12. Int J Cancer. 2011. PMID: 20830712 Free article.

5

The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1.

Daubriac J, Han S, Grahovac J, Smith E, Hosein A, Buchanan M, Basik M, Boucher Y. Daubriac J, et al. Among authors: buchanan m. Oncotarget. 2017 Dec 28;9(12):10375-10387. doi: 10.18632/oncotarget.23735. eCollection 2018 Feb 13. Oncotarget. 2017. PMID: 29535813 Free PMC article.

6

Precision Medicine Tools to Guide Therapy and Monitor Response to Treatment in a HER-2+ Gastric Cancer Patient: Case Report.

Aguilar-Mahecha A, Joseph S, Cavallone L, Buchanan M, Krzemien U, Batist G, Basik M. Aguilar-Mahecha A, et al. Among authors: buchanan m. Front Oncol. 2019 Aug 6;9:698. doi: 10.3389/fonc.2019.00698. eCollection 2019. Front Oncol. 2019. PMID: 31448226 Free PMC article.

7

A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability.

Sirois I, Aguilar-Mahecha A, Lafleur J, Fowler E, Vu V, Scriver M, Buchanan M, Chabot C, Ramanathan A, Balachandran B, Légaré S, Przybytkowski E, Lan C, Krzemien U, Cavallone L, Aleynikova O, Ferrario C, Guilbert MC, Benlimame N, Saad A, Alaoui-Jamali M, Saragovi HU, Josephy S, O'Flanagan C, Hursting SD, Richard VR, Zahedi RP, Borchers CH, Bareke E, Nabavi S, Tonellato P, Roy JA, Robidoux A, Marcus EA, Mihalcioiu C, Majewski J, Basik M. Sirois I, et al. Among authors: buchanan m. Mol Cancer Res. 2019 Dec;17(12):2492-2507. doi: 10.1158/1541-7786.MCR-19-0264. Epub 2019 Sep 19. Mol Cancer Res. 2019. PMID: 31537618

8

The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.

Légaré S, Cavallone L, Mamo A, Chabot C, Sirois I, Magliocco A, Klimowicz A, Tonin PN, Buchanan M, Keilty D, Hassan S, Laperrière D, Mader S, Aleynikova O, Basik M. Légaré S, et al. Among authors: buchanan m. Cancer Res. 2015 Oct 15;75(20):4351-63. doi: 10.1158/0008-5472.CAN-14-3475. Epub 2015 Aug 21. Cancer Res. 2015. PMID: 26297734

9

An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy.

Darini C, Ghaddar N, Chabot C, Assaker G, Sabri S, Wang S, Krishnamoorthy J, Buchanan M, Aguilar-Mahecha A, Abdulkarim B, Deschenes J, Torres J, Ursini-Siegel J, Basik M, Koromilas AE. Darini C, et al. Among authors: buchanan m. Nat Commun. 2019 May 13;10(1):2139. doi: 10.1038/s41467-019-10138-8. Nat Commun. 2019. PMID: 31086176 Free PMC article.

10

Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL. Luga V, et al. Among authors: buchanan m. Cell. 2012 Dec 21;151(7):1542-56. doi: 10.1016/j.cell.2012.11.024. Cell. 2012. PMID: 23260141 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

564 results

Search Page